Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/1483
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMiraxmedova Xilola To'xtasinovna, Nizametdinova Ulugoy Jaminovna, Saidrasulova Gulizebo Baxtiyor qizi-
dc.date.accessioned2025-05-23T04:34:26Z-
dc.date.available2025-05-23T04:34:26Z-
dc.date.issued2025-
dc.identifier.issn2181-7812-
dc.identifier.urihttp://repo.tma.uz/xmlui/handle/1/1483-
dc.description.abstractObjective: To study the significance of metabolic fatty liver disease and asymptomatic hyperuricemia in osteoarthritis. Material and methods: The study included 70 patients aged 45 to 75 years with a confirmed diagnosis of osteoarthritis of the knee and hip joints, admitted for treatment to the rheumatology and cardiorheumatology departments of the multidisciplinary clinic of the Tashkent Medical Academy in 2024. The duration of the disease was on average from 2 to 10 years. Results: Of the total number of patients, 78.6% suffered from gonarthrosis of the knee joints, 21.4% - arthrosis of the hip joint. The average pain score on the WOMAC scale was 13.2±1.35, numbness - 4.20±2.26, functional impairment - 43.8±12.3. Conclusions: Osteoarthritis is a leading cause of morbidity, disability and loss of productivity worldwide. Osteoarthritis is associated with a number of systemic diseases, such as obesity, cardiovascular diseases, type 2 diabetes mellitus, metabolic syndrome.en_US
dc.language.isootheren_US
dc.publisherToshkent tibbiyot akademiyasi axborotnomasien_US
dc.subjectosteoarthritis, metabolic syndrome, asymptomatic hyperuricemia, uric acid, metabolic fatty liver disease.en_US
dc.title"OSTEOARTRIT KASALLIGIDA SIMPTOMSIZ GIPERURIKEMIYANING VA METABOLIK JIGAR YOG‘ KASALLIGINING AHAMIYATI"en_US
dc.typeArticleen_US
Appears in Collections:Articles

Files in This Item:
File Description SizeFormat 
22. OSTEOARTRIT KASALLIGIDA SIMPTOMSIZ GIPERURIKEMIYANING VA METABOLIK JIGAR YOG‘.pdf994.15 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.